Intact and cleaved uPAR forms: diagnostic and prognostic value in cancer

Citations Over TimeTop 12% of 2008 papers

Abstract

The cellular receptor for urokinase, uPAR, localizes its ligand, uPA, and thereby the plasminogen activation, to the cell surface. uPA also cleaves uPAR, liberating the ligand-binding domain I, and thereby inactivates the binding potential of uPAR for both uPA and vitronectin. The uPA-catalyzed cleavage of uPAR is fast on the cell surface, when uPA is bound to a neighboring uPAR molecule. uPAR can be shed from the cell surface. However, the soluble form cannot be cleaved by uPA. Glycolipid-anchored and soluble forms of intact, uPAR(I-III), and cleaved receptor, uPAR(II-III) and uPAR(I), have been identified in tissue and body fluids. It is well-established, that the total amount of all uPAR forms is a strong prognostic marker in different types of cancer. Using immunoassays, measuring the individual uPAR forms, has revealed that the cleaved uPAR forms are even stronger prognostic markers and have diagnostic utility. This review will focus on the mechanism of uPAR cleavage and the functional consequences, as well as the clinical applicability of cleaved uPAR forms.

Related Papers

• → Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes(2008)115 cited
• → The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction(1997)140 cited
• → The interaction between urokinase receptor and vitronectin in cell adhesion and signalling(2008)113 cited
• → Domain 1 of the urokinase receptor (uPAR) is required for uPAR‐mediated cell binding to vitronectin(2000)78 cited
• → Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL‐4, IL‐10 and IL‐13: consequences on cell adhesion to vitronectin and fibrinogen(1998)21 cited